White House touts record drug-price drop, but critics say the claim oversimplifies the data

The administration highlighted a recent Consumer Price Index report showing prescription drug prices fell 3.1% over the 12 months ending in July, the steepest annual decline since 1963, and dropped 0.8% from June to July.

Officials credited the decline to initiatives such as the TrumpRx consumer website and executive actions, presenting the trend as a major achievement of the current administration.

Analysts pointed out that the headline figure does not capture the full picture, noting that short‑term fluctuations and broader market forces can influence the CPI reading.

Critics described the messaging as political spin, arguing that the data alone does not prove lasting affordability improvements for patients.